These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32565225)

  • 1. Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview.
    Hashida M
    Adv Drug Deliv Rev; 2020; 157():71-82. PubMed ID: 32565225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation-mediated targeting of carriers.
    Kawakami S; Hashida M
    J Control Release; 2014 Sep; 190():542-55. PubMed ID: 24915504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations for targeted drug delivery.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2013 Jan; 65(1):139-47. PubMed ID: 23280371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of gene drug delivery systems based on pharmacokinetic studies.
    Takakura Y; Nishikawa M; Yamashita F; Hashida M
    Eur J Pharm Sci; 2001 Apr; 13(1):71-6. PubMed ID: 11292570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of drug delivery systems for macromolecular drugs].
    Takakura Y
    Yakugaku Zasshi; 1996 Jul; 116(7):519-32. PubMed ID: 8831257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based drug carriers for prodrugs to enhance drug delivery.
    Zaro JL
    AAPS J; 2015 Jan; 17(1):83-92. PubMed ID: 25269430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.
    Loyer P; Cammas-Marion S
    J Drug Target; 2014 Aug; 22(7):556-75. PubMed ID: 25012064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.
    Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):820-31. PubMed ID: 8792417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in prodrug design.
    Silva AT; Chung MC; Castro LF; Güido RV; Ferreira EI
    Mini Rev Med Chem; 2005 Oct; 5(10):893-914. PubMed ID: 16250833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-based drug delivery.
    Alsaggar M; Liu D
    J Drug Target; 2018; 26(5-6):385-397. PubMed ID: 29419330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.
    Ojer P; Iglesias T; Azqueta A; Irache JM; López de Cerain A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):206-17. PubMed ID: 26493712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal carriers for the enhanced delivery through the skin.
    Cosco D; Celia C; Cilurzo F; Trapasso E; Paolino D
    Expert Opin Drug Deliv; 2008 Jul; 5(7):737-55. PubMed ID: 18590459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Drug Conjugate for Enhancing Drug Delivery.
    Irby D; Du C; Li F
    Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal and transdermal delivery: prodrugs.
    Sloan KB; Devarajan-Ketha H; Wasdo SC
    Ther Deliv; 2011 Jan; 2(1):83-105. PubMed ID: 22833927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.